Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 278,712
  • Shares Outstanding, K 58,308
  • Annual Sales, $ 192,640 K
  • Annual Income, $ 2,510 K
  • EBIT $ -31 M
  • EBITDA $ -37 M
  • 60-Month Beta 0.76
  • Price/Sales 1.45
  • Price/Cash Flow N/A
  • Price/Book 0.51

Options Overview Details

View History
  • Implied Volatility 85.07% ( +3.86%)
  • Historical Volatility 37.71%
  • IV Percentile 86%
  • IV Rank 53.64%
  • IV High 142.61% on 10/24/24
  • IV Low 18.50% on 09/26/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 300
  • Volume Avg (30-Day) 161
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 4,228
  • Open Int (30-Day) 9,419

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +4.94%
on 12/11/24
5.42 -13.84%
on 11/27/24
-0.42 (-8.25%)
since 11/22/24
3-Month
4.35 +7.36%
on 10/10/24
5.55 -15.78%
on 11/12/24
-0.08 (-1.68%)
since 09/23/24
52-Week
3.46 +34.97%
on 02/06/24
6.75 -30.81%
on 06/13/24
+0.70 (+17.63%)
since 12/22/23

Most Recent Stories

More News
New Strong Buy Stocks for November 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings...

TSQ : 9.65 (-0.72%)
SPPJY : 2.7950 (-1.93%)
VMEO : 6.93 (+3.13%)
TBI : 8.20 (-1.68%)
VNDA : 4.65 (-2.72%)
Vanda: Q3 Earnings Snapshot

Vanda: Q3 Earnings Snapshot

VNDA : 4.65 (-2.72%)
Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More

Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.Here's...

JAZZ : 123.00 (+0.02%)
EXEL : 33.26 (-0.09%)
NVAX : 8.58 (-1.38%)
VNDA : 4.65 (-2.72%)
Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

A regulator's decision drained the market's enthusiasm for the company.

VNDA : 4.65 (-2.72%)
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...

ALZN : 1.1300 (+1.80%)
VNDA : 4.65 (-2.72%)
ITCI : 83.53 (+0.10%)
TEVA : 22.03 (-0.27%)
ABBV : 176.35 (+0.44%)
Vanda: Q2 Earnings Snapshot

Vanda: Q2 Earnings Snapshot

VNDA : 4.65 (-2.72%)
Accenture, KB Home rise; Snap, Jabil fall, Thursday, 6/20/2024

Stocks that traded heavily or had substantial price changes on Thursday: Accenture, KB Home rise; Snap, Jabil fall

CG : 50.27 (+0.10%)
CMC : 49.93 (-0.68%)
VNDA : 4.65 (-2.72%)
DFS : 173.32 (+0.09%)
SNAP : 11.15 (-2.19%)
KBH : 65.66 (-0.30%)
ACN : 358.39 (-2.18%)
Vanda: Q1 Earnings Snapshot

Vanda: Q1 Earnings Snapshot

VNDA : 4.65 (-2.72%)
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Future Pak wants Vanda, but Vanda doesn't want Future Pak.

VNDA : 4.65 (-2.72%)
Vanda: Q4 Earnings Snapshot

Vanda: Q4 Earnings Snapshot

VNDA : 4.65 (-2.72%)

Business Summary

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics...

See More

Key Turning Points

3rd Resistance Point 5.12
2nd Resistance Point 4.97
1st Resistance Point 4.88
Last Price 4.65
1st Support Level 4.64
2nd Support Level 4.49
3rd Support Level 4.40

See More

52-Week High 6.75
Fibonacci 61.8% 5.49
Fibonacci 50% 5.11
Fibonacci 38.2% 4.72
Last Price 4.65
52-Week Low 3.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar